The metric properties of a novel non‐motor symptoms scale for Parkinson's disease: Results from an international pilot study
- K. Chaudhuri, P. Martínez-Martín, A. Schapira
- Psychology, MedicineMovement Disorders
- 15 October 2007
NMSS can be used to assess the frequency and severity of NMS in PD patients across all stages in conjunction with the recently validated non‐motor questionnaire.
The Parkinson Progression Marker Initiative (PPMI)
- K. Marek, D. Jennings, Peggy Taylor
- BiologyProgress in neurobiology
- 1 December 2011
The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease
- P. Barone, A. Antonini, P. Dotto
- Psychology, MedicineMovement Disorders
- 15 August 2009
A key role for NMS in the clinical frame of PD is supported and the need to address them specifically in clinical trials using dedicated scales is addressed.
Depression rating scales in Parkinson's disease: Critique and recommendations
A systematic literature review was conducted to explore the use of depression scales in PD and determine which scales should be selected, and found that the complex and time‐consuming task of developing a new scale to measure depression specifically for patients with PD is currently not warranted.
International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study
- K. Chaudhuri, P. Martínez-Martín, C. Olanow
- Medicine, PsychologyMovement Disorders
- 1 July 2006
An international pilot study assessing feasibility, validity, and acceptability of a nonmotor questionnaire (NMSQuest) found NMS were highly significantly more prevalent across all disease stages and the number of symptoms correlated significantly with advancing disease and duration of disease.
MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.
- A. Quattrone, G. Nicoletti, O. Gallo
- MedicineRadiology
- 2008
The MR parkinsonism index can help distinguish patients with PSP from those with PD and MSA-P on an individual basis.
The natural history of multiple system atrophy: a prospective European cohort study
- G. Wenning, F. Geser, W. Poewe
- MedicineLancet Neurology
- 1 March 2013
Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease
- A. Tessitore, F. Esposito, G. Tedeschi
- Psychology, BiologyNeurology
- 4 December 2012
The findings revealed a functional disruption of the DMN in cognitively unimpaired patients with PD, in the absence of significant structural differences between patients and controls.
Mild cognitive impairment in Parkinson disease
- D. Aarsland, K. Brønnick, M. Emre
- Psychology, MedicineNeurology
- 21 September 2010
Having MCI was associated with older age at assessment and at disease onset, male gender, depression, more severe motor symptoms, and advanced disease stage, and future studies of patients with PD with MCI need to determine risk factors for ongoing cognitive decline and assess interventions at a predementia stage.
Resting-state brain connectivity in patients with Parkinson's disease and freezing of gait.
- A. Tessitore, M. Amboni, P. Barone
- Medicine, PsychologyParkinsonism & Related Disorders
- 1 July 2012
...
...